Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iTAP: Tenofovir for Prevention of Perinatal HBV Transmission
NCT01745822Phase 3Completed
- Sponsor
- Institut de Recherche pour le Développement
- Start
- Jan 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate in hepatitis B (HBV), sponsored by Institut de Recherche pour le Développement. Started Jan 2013; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01745822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01745822.